sgc001
mAbexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 20, 2024 (NCT07079618)
Timeline
Indications
Mechanism of action
- UnclearINHIBITOR
Unclear inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07306182 | Phase 2 | Feb 28, 2026 | Government of China |
| NCT07091929 | Phase 1 | Jan 20, 2025 | Government of China, Harbin Medical University |
| NCT07079618 | Phase 1 | Aug 20, 2024 | Capital Medical University, Government of China |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of China | Government | 3 | 3 | 2 | 2024 |
| Capital Medical University | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Harbin Medical University | Academic/Hospital | 1 | 0 | 1 | 2025 |
3 organizations
Page 1 / 1